Enhanced bladder capacity and reduced prostaglandin E2-mediated bladder hyperactivity in EP3 receptor knockout mice

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 2, 2008, Pages

  McCafferty, Gerald P ^a   Misajet, Blake A ^a   Laping, Nicholas J ^a   Edwards, Richard M ^a   Thorneloe, Kevin S ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Conscious cystometry; GR63799X

Indexed keywords

ACETIC ACID; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E3 RECEPTOR; UNCLASSIFIED DRUG; GR 63799X; ISOPROTEIN; PROSTAGLANDIN E; PROSTAGLANDIN EP3 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BLADDER CAPACITY; BLADDER FUNCTION; BLADDER PRESSURE; CONTROLLED STUDY; CYSTOMETRY; GENOTYPE; MALE; MOUSE; NONHUMAN; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROTEIN FUNCTION; URODYNAMICS; ANIMAL; BLADDER; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY;

ACETIC ACID; ANIMALS; DINOPROSTONE; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROSTAGLANDINS E, SYNTHETIC; PROTEIN ISOFORMS; RECEPTORS, PROSTAGLANDIN E; URINARY BLADDER; URINARY BLADDER, OVERACTIVE;

EID: 52449117189     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00054.2008     Document Type: Article

References (36)

1. Angelico P, Guarneri L, Velasco C, Cova R, Leonardi A, Clarke DE, Testa R. Effect of cyclooxygenase inhibitors on the micturition reflex in rats: correlation with inhibition of cyclooxygenase isozymes. BJU Int 97: 837-846, 2006.
2. Araki T, Yokoyama T, Kumon H. Effectiveness of a nonsteroidal anti-inflammatory drugs for nocturia in patients with benign prostatic hyperplasia: a prospective nonrandomized study of Loxoprofen sodium 60 mg once daily before sleeping. Acta Med Okayama 58: 45-49, 2004.
3. Bingham S, Beswick PJ, Blum DE, Gray NM, Chessell IP. The role of the cyclooxygenase pathway in nociception and pain. Semin Cell Dev Biol 17: 544-554, 2006.
4. Cardozo LD, Stanton SL. A comparison between bromocriptine and indomethacin in the treatment of detrusor instability. J Urol 123: 399-401, 1980.
5. Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L, Hedley L, Lachnit WG, Burnstock G, McMahon SB, Ford AP. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407: 1011-1015, 2000.
6. Dionne R. Relative efficacy of selective COX-2 inhibitors compared with over-the-counter ibuprofen. Int J Clin Pract Suppl 135: 18-22, 2003.
7. Dveksler G, Franchi AM, Gonzalez ET, Gimeno MA, Gimeno AL. Electric field stimulation alters the outputs of prostaglandins from isolated rat urinary bladder preparations. Influences of papaverine and tetradotoxin. Prostaglandins Leukot Essent Fatty Acids 36: 65-68, 1989.
8. 2. Am J Physiol Renal Physiol 275: F955-F961, 1998.
9. Hao CM, Breyer MD. Physiological regulation of prostaglandins in the kidney. Annu Rev Physiol 70: 357-377, 2008.
10. Herrera GM, Pozo MJ, Zvara P, Petkov GV, Bond CT, Adelman JP, Nelson MT. Urinary bladder instability induced by selective suppression of the murine small conductance calcium-activated potassium (SK3) channel. J Physiol 551: 893-903, 2003.
11. Hu VY, Malley S, Dattilio A, Folsom JB, Zvara P, Vizzard MA. COX-2 and prostanoid expression in micturition pathways after cyclophosphamide- induced cystitis in the rat. Am J Physiol Regul Integr Comp Physiol 284: R574-R585, 2003.
12. 2-induced bladder hyperactivity in normal, conscious rats: involvement of tachykinins? J Urol 153: 2034-2038, 1995.
13. 2 and indomethacin on micturition. Br J Urol 53: 21-28, 1981.
14. Kim JC, Park EY, Hong SH, Seo SI, Park YH, Hwang TK. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom. Int J Urol 12: 875-880, 2005.
15. Kim JC, Park EY, Seo SI, Park YH, Hwang TK. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 175: 1773-1776, 2006.
16. Lee T, Hedlund P, Newgreen D, Andersson KE. Urodynamic effects of a novel EP1 receptor antagonist in normal rats and rats with bladder outlet obstruction. J Urol 177: 1562-1567, 2007.
17. Maggi CA, Giuliani S, Conte B, Furio M, Santicioli P, Meli P, Gragnani L, Meli A. Prostanoids modulate reflex micturition by acting through capsaicin-sensitive afferents. Eur J Pharmacol 145: 105-112, 1988.
18. Maggi CA, Giuliani S, Patacchini R, Conte B, Furio M, Santicioli P, Meli P, Gragnani L, Meli A. The effect of SC-19220, a prostaglandin antagonist, on the micturition reflex in rats. Eur J Pharmacol 152: 273-279, 1988B.
19. 2 release from isolated bladder strips in rats with spinal cord injury. Int J Urol 13: 271-276, 2006.
20. 2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Br J Pharmacol 133: 438-444, 2001.
21. Mitsui T, Kakizaki H, Matsuura S, Ameda K, Yoshioka M, Koyanagi T. Afferent fibers of the hypogastric nerves are involved in the facilitating effects of chemical bladder irritation in rats. J Neurophysiol 86: 2276-2284, 2001.
22. Oida H, Namba T, Sugimoto Y, Ushikubi F, Ohishi H, Ichikawa A, Narumiya S. In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. Br J Pharmacol 116: 2828-2837, 1995.
23. Palea S, Toson G, Pietra C, Trist DG, Artibani W, Romano O, Corsi M. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder. Br J Pharmacol 124: 865-872, 1998.
24. Park JM, Yang T, Arend LJ, Schnermann JB, Peters CA, Freeman MR, Briggs JP. Obstruction stimulates COX-2 expression in bladder smooth muscle cells via increased mechanical stretch. Am J Physiol Renal Physiol 276: F129-F136, 1999.
25. Park JM, Yang T, Arend LJ, Smart AM, Schnermann JB, Briggs JP. Cyclooxygenase-2 is expressed in bladder during fetal development and stimulated by outlet obstruction. Am J Physiol Renal Physiol 273: F538-F544, 1997.
26. Pinna C, Zanardo R, Puglisi L. Prostaglandin release impairment in the bladder epithelium of streptozotocin-induced diabetic rats. Eur J Pharmacol 388: 267-273, 2000.
27. Saito M, Kawatani M, Kinoshita Y, Satoh K, Miyagawa I. Effectiveness of anti-inflammatory drug, loxoprofen, for patients with nocturia. Int J Urol 12: 779-782, 2005.
28. Sanchez-Alavez M, Klein I, Brownell SE, Tabarean IV, Davis CN, Conti B, Bartfai T. Night eating and obesity in the EP3R-deficient mouse. Proc Natl Acad Sci USA 104: 3009-3014, 2007.
29. 2 and bladder outlet obstruction in wild-type and Ep1 receptor knockout mice. J Urol 172: 1166-1170, 2004.
30. 2 derivative, on the lower urinary tract in healthy women. A urodynamic study. Urol Res 18: 349-352, 1990.
31. 2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data. J Pharmacol Exp Ther 286: 1094-1102, 1998.
32. Takagi-Matsumoto H, Ng B, Tsukimi Y, Tajimi M. Effects of NSAIDs on bladder function in normal and cystitis rats: a comparison study of aspirin, indomethacin, and ketoprofen. J Pharm Sci 95: 458-465, 2004.
33. Thorneloe KS, Meredith AL, Knorn AM, Aldrich RW, Nelson MT. Urodynamic properties and neurotransmitter dependence of urinary bladder contractility in the BK channel deletion model of overactive bladder. Am J Physiol Renal Physiol 289: F604-F610, 2005.
34. Vlaskovska M, Kasakov L, Rong W, Bodin P, Bardini M, Cockayne DA, Ford AP, Burnstock G. P2X3 knockout mice reveal a major sensory role for urothelially released ATP. J Neurosci 21: 5670-5677, 2001.
35. 2 potentiation of P2X3 receptor mediated currents in dorsal root ganglion neurons. Mol Pain 3: 22-34, 2007.
36. Wibberley A, McCafferty GP, Evans C, Edwards RM, Hieble JP. Dual, but not selective, COX-1 and COX-2 inhibitors attenuate acetic acid-evoked bladder irritation in the anaesthetised female cat. Br J Pharmacol 148: 154-161, 2006.